Can a PET-CT Scan — Cause Cancer?

Both. A PET-CT scan involves two distinct sources of radiation. The radioactive tracer injected before the scan emits radiation from inside your body for several hours until its activity fades naturally. The CT scanner adds a second dose through X-rays during the scan itself. Together these make up the total radiation exposure. The CT component varies depending on how many body regions are covered and the technical settings the radiologist uses.

The tracer used in most PET scans is labelled with a radioactive atom that has a short half-life — its radioactivity halves repeatedly in the hours after injection, so the large majority of its activity has already decayed by the time you arrive home. Your kidneys actively clear the tracer through urine as well, which is why drinking water helps. By the following morning, the radioactivity has reduced to a level where no precautions are needed. This is very different from radiation therapy, where the dose is absorbed — the PET tracer clears your body on its own.

It is a reasonable concern, and it is worth raising directly with your oncologist. Each scan adds a small increment to your cumulative radiation dose, and those increments do accumulate over time. At the same time, your team orders repeat scans because the information each one provides drives decisions that matter for your treatment — whether the cancer has responded, whether it has changed. Ask why each scan is planned and what it is expected to show. When the clinical need for each scan is clear, the benefit of that information generally justifies the added dose.

PET-CT is generally avoided during pregnancy unless there is an urgent and compelling clinical reason. The developing baby is considerably more sensitive to radiation than adult tissue, and the radiotracer can cross the placenta. If you are pregnant, or think you might be, tell your team before any scan is arranged — do not wait until the appointment day. Your team will reassess whether the scan is still needed, whether it can be safely timed differently, or whether an alternative test provides the same information without radiation.

For a few hours after the scan, you do carry a low level of radioactivity from the tracer. Radiology teams advise limiting prolonged, close contact with young children and pregnant women for the rest of the day — not because a brief hug is dangerous, but because reducing unnecessary exposure is standard precaution. By the following morning, the tracer's activity has reduced enough that no restrictions apply. You do not need to sleep in a separate room or avoid your family; the guidance applies to extended close contact on the day of the scan itself.

Prior radiation therapy means your body has already received a significant dose to a specific area, and cumulative radiation exposure is something your team is trained to track. The dose from a PET-CT scan is much smaller than a course of radiation therapy, and the two are different in type, amount, and the area they affect. Whether a further PET-CT is appropriate depends on the clinical need in your particular situation. Tell your oncologist about your treatment history so they can consider it as part of their decision.

Your fear is completely understandable, and it is the right question to ask directly. What is also true is that your oncologist has assessed your specific situation and decided that the information from this scan matters for your care. Ask them to explain what clinical question the scan is answering and what they will do differently based on the result. When you understand exactly what is at stake, the balance between a small radiation risk and a clear clinical benefit usually becomes clearer. If you remain uncertain after that conversation, you are entirely entitled to ask for a second opinion before deciding.

Generally yes, because a PET-CT adds the radiation from the radioactive tracer on top of the CT component. A standard CT scan alone typically involves less total radiation than a combined PET-CT. Both are within the range of medical imaging doses that ICRP guidance describes as carrying individually small lifetime risks, weighed against the clinical benefit that justified ordering them. The comparison matters less than understanding why your team has chosen one test over the other — that decision is driven by what clinical question needs answering, not by radiation dose alone.